--- title: Phase II Clinical Trials CROs in India path: /services/phase-2-clinical-trials/india companies_count: 20 --- # Phase II Clinical Trials CROs in India 20 published CROs match Phase II Clinical Trials in India. Locations in this set include India, United States, United Kingdom, Australia, China, and Bulgaria. Capabilities that show up most often in this set: Biologics (Other), Vaccine, Small Molecule, Cell Therapy, and Gene Therapy. ## Matching companies - [Accutest Research Laboratories](/companies/accutestglobal) - Independent Indian CRO focused on BA/BE studies, Phase II–IV clinical development, and biologics bioanalysis. Operates 262 clinic beds and 21 LC-MS/MS systems across Mumbai and Vadodara. - [BioAgile Therapeutics](/companies/bioagiletherapeutics) - ISO 9001:2015-certified CRO offering end-to-end clinical research services including Phase I–IV trials, medical writing, biostatistics, data management, and regulatory support across pharmaceuticals, nutraceuticals, devices, and biotech. - [Clinical Research Network India Pvt. Ltd.](/companies/crnindia) - Clinical Research Organization offering Phase I–IV clinical trials, pharmacovigilance, medical writing, regulatory affairs, and data management services with 15+ years of experience across cardiology, oncology, vaccines, and medical devices. - [Emerald Clinical](/companies/emeraldclinical) - Global clinical research organization with 25+ years of expertise, headquartered in Singapore with operations across Asia-Pacific, EMEA, and the Americas. Specializes in renal, oncology, cardiovascular, and early-phase research with deep scientific leadership and proven operational excellence. - [ICBio](/companies/icbiocro) - ICBio is a Bengaluru-based CRO offering bioavailability/bioequivalence studies, phase II–IV clinical trials, and LC-MS/MS bioanalysis. The excerpts cite regulatory approvals from DCGI-CDSCO, ANVISA, and EMA. - [ICON plc](/companies/iconplc) - ICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs. - [Innovate Research](/companies/innovate-research) - Indian CRO providing end-to-end clinical trial services (Phase I–IV), regulatory support, medical writing, biostatistics, data management, and biospecimen procurement across pharmaceuticals, biologics, medical devices, and nutraceuticals. - [JSS Medical Research](/companies/jssresearch) - Full-service CRO with over 30 years of experience offering clinical trials, biostatistics, medical writing, and health economics services across all phases of development. - [Krescent Medical Research](/companies/krescentmr) - Full-service preclinical and clinical CRO supporting pharmaceutical, biotechnology, and medical device companies with trial design, site selection, data management, statistical analysis, and medical writing across Asia-Pacific. - [MPREX](/companies/mprex) - MPREX is a contract research organization in Pune, India, specializing in clinical trials in dermatology and claim-substantiation studies for skin and hair care products, with laboratory testing for product efficacy and safety. - [PPD](/companies/ppd) - PPD is a leading global contract research organization (CRO) and the clinical research business of Thermo Fisher Scientific. - [Perceptive](/companies/perceptive) - Leading clinical research organization providing preclinical to late-phase imaging, randomization and trial supply management (RTSM), and eClinical services to the global biopharmaceutical industry. - [Premier Research](/companies/premier-research) - Premier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing. - [ProRelix Research](/companies/prorelixresearch) - ProRelix Research supports Phase 1–4 clinical trials across pharmaceutical, biotechnology, and medical device sectors, offering clinical trial project management, data management, and medical writing services in compliance with ICH and GCP principles across the US, India, Europe, and Australia. - [QPS](/companies/qps) - QPS provides integrated contract research and clinical services spanning bioanalysis, preclinical development, and early-to-late phase clinical trials across multiple therapeutic areas including oncology, dermatology, and women's health. - [Raptim Research](/companies/raptimresearch) - Bioequivalence and bioavailability specialist with 32+ USFDA inspections cleared, running healthy-subject BA/BE and PK/PD studies, IVRT/IVPT in-vitro release and permeability testing, and Phase I to IV clinical trials. - [SMO India Clinical Research Pvt Ltd](/companies/smo-india) - CDSCO-registered CRO with 25+ years of clinical trial experience across Phase I–IV studies in India. Specializes in site management, clinical operations, and regulatory affairs across diverse therapeutic areas. - [Signant Health](/companies/signanthealth) - Clinical trial technology and services provider with 30 years of experience supporting thousands of trials and 25% of novel drug approvals (FDA/EMA, 2021–2024). Offers eClinical solutions, protocol guidance from 50+ in-house scientists and clinicians, and global operational scale. - [Syngene International](/companies/syngeneintl) - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S. - [Veranex](/companies/quartesian) - Veranex is an Innovation CRO uniting design, preclinical, clinical, regulatory, and market-access expertise for medical devices and diagnostics. The company accelerates development from concept through commercialization with integrated cross-disciplinary teams across 15 international hubs.